Intravenous basic fibroblast growth factor does not ameliorate brain injury resulting from transient focal ischemia in cats

Journal of Neurosurgical Anesthesiology

Volumn 10, Issue 3, 1998, Pages 160-165

  Harukuni, Izumi ^a   Traystman, Richard J ^a   Bhardwaj, Anish ^a   Koehler, Raymond C ^a   Kirsch, Jeffrey R ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Dept Anesth Critical Care Medicine ^*  (United States)

Author keywords

Middle cerebral artery occlusion; Neuroprotection; Somatosensory evoked potential; Triphenyltetrazolium staining

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; BRAIN PROTECTION; CAT; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE;

EID: 0031846297     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-199807000-00006     Document Type: Article

References (35)

1. Anderson KJ, Dam D, Lee S, Cotman CW. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 1988;332:360-1.
2. Finklestein SP, Apostolides PJ, Caday CG, et al. Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res 1988;460:253-9.
3. Takami K, Iwane M, Kiyota Y, et al. Increase of basic fibroblast growth factor immunoreactivity and its mRNA level in rat brain following transient forebrain ischemia. Exp Brain Res 1992;90:1-10.
4. Lippoldt A, Andbjer B, Rosen L, et al. Photochemically induced focal cerebral ischemia in rat: time dependent and global increase in expression of basic fibroblast growth factor mRNA. Brain Res 1993;625:45-56.
5. Yamada E, Kataoka H, Chue C-H, Hazama F. Expression of basic fibroblast growth factor in astrocytes at the site of cerebral lesions and edematous areas under chronic hypertension. Acta Neurochir Suppl (Wien) 1994;60:265-7.
6. Yamada K, Sakaguchi T, Yuguchi T, et al. Blood-borne macromolecule induces FGF receptor gene expression after focal ischemia. Acta Neurochir Suppl (Wien) 1994;60:261-4.
7. Yamada K, Kinoshita A, Kohmura E, et al. Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. J Cereb Blood Flow Metab 1991;11:472-8.
8. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 1996;16:542-7.
9. Koketsu N, Berlove DJ, Moskowitz MA, et al. Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann Neurol 1994;35:451-7.
10. Tenjin H, Anderson RE, Meyer FB. Treatment with basic fibroblastic growth factor following focal cerebral ischemia does not prevent neuronal injury. J Neurol Sci 1995;128:66-70.
11. Hondermarck H, Courty J, Boilly B, Thomas D. Distribution of intravenously administered acidic and basic fibroblast growth factors in the mouse. Experientia 1990;46:973-4.
12. Cuevas P, Fernandez-Ayerdi A, Carceller F, et al. Central nervous system distribution of fibroblast growth factor injected into the blood stream. Neurol Res 1996;18:267-72.
13. Rosenblatt S, Irikura K, Caday CG, et al. Basic fibroblast growth factor dilates rat pial arterioles. J Cereb Blood Flow Metab 1994;14:70-4.
14. Tanaka R, Miyasaka Y, Yada K, et al. Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model. Stroke 1995;26:2154-9.
15. Nozaki K, Finklestein SP, Beal MF. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J Cereb Blood Flow Metab 1993;13:221-8.
16. Kirschner PB, Henshaw R, Weise J, et al. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J Cereb Blood Flow Metab 1995;15:619-23.
17. Jiang N, Finklestein SP, Do T, et al. Delayed intravenous administration of basis fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J Neurol Sci 1996;139:173-9.
18. Fisher M, Meadows M-E, Do T, et al. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1995;15:953-9.
19. Tatlisumak T, Takano K, Carano RA, Fisher M. Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging. Stroke 1996;27:2292-7.
20. Bethel A, Kirsch JR, Koehler RC, et al. Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke 1997;28:609-15.
21. Roberts TP, Vexler ZS, Derugin N, et al. Evaluation of recombinant human basic fibroblast growth factor (rhbFGF) as a cerebroprotective agent using high speed MR imaging. Brain Res 1995;699:51-61.
22. Matsumiya N, Koehler RC, Traystman RJ. Consistency of cerebral blood flow and evoked potential alterations with reversible focal ischemia in cats. Stroke 1990;21:908-16.
23. Matsumiya N, Koehler RC, Kirsch JR, Traystman RJ. Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke 1991;22:1193-200.
24. Ren JM, Finklestein SP. Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia. Eur J Pharmacol 1997;327:11-6.
25. O'Brien MD, Waltz AG. Transorbital approach for occluding the middle cerebral artery without craniectomy. Stroke 1973;4:201-6.
26. Takahashi H, Kirsch JR, Hashimoto K, et al. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine, a potent &-receptor ligand, decreases brain injury following transient focal ischemia in cats. Stroke 1995;26:1676-82.
27. Nishikawa T, Kirsch JR, Koehler RC, et al. Nitric oxide synthase inhibition reduces caudate injury following transient focal ischemia in cats. Stroke 1994;25:877-85.
28. Baskin DS, Widmayer MA, Browning JL, et al. Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats. Stroke 1994;25:2047-54.
29. Bederson JB, Pitts LH, Germano SM, et al. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986;17:1304-8.
30. Cole DJ, Drummond JC, Ghazal EA, Shapiro HM. A reversible component of cerebral injury as identified by the histochemical stain 2,3,5-triphenyltetrazolium chloride (TTC). Acta Neuropathol 1990;80:152-5.
31. Takeshima R, Kirsch JR, Koehler RC, et al. Monoclonal leukocyte antibody (MoAb 60.3) does not decrease injury following transient focal cerebral ischemia in cats. Stroke 1992;23:247-52.
32. Ren JM, Kawamata T, Chen K, et al. Time dependence of infarct reduction by intravenous basic fibroblast growth factor (bFGF) following focal ischemia. [Abstract] J Cereb Blood Flow Metab 1997;17:S377
33. Tiefenbacher CP, Chilian WM. Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation. Cardiovasc Res 1997;34:411-7.
34. Gomez-Pinilla F, Miller S, Choi J, Cotman CW. Heparan sulfate potentiates the autocrine action of basic fibroblast growth factor in astrocytes: an in vivo and in vitro study. Neuroscience 1997;76:137-45.
35. Medalion B, Merin G, Aingorn H, et al. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall. Circulation 1997;95:1853-62.